These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 37655078)

  • 1. Expression of DKK1 in Endometrial Endometrioid Carcinoma and Its Correlation with Wnt/β-catenin Signalling Pathway.
    Das A; Mathur SR; Kumar S; Bhatla N
    Sultan Qaboos Univ Med J; 2023 Aug; 23(3):303-310. PubMed ID: 37655078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matrix metalloproteinases 2 and 9, E-cadherin, and beta-catenin expression in endometriosis, low-grade endometrial carcinoma and non-neoplastic eutopic endometrium.
    Shaco-Levy R; Sharabi S; Benharroch D; Piura B; Sion-Vardy N
    Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):226-32. PubMed ID: 18295959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expression of beta-catenin, Glut-1, PTEN proteins in uterine endometrioid adenocarcinoma and its precursor lesions].
    Xiong Y; Xiong YY; Zhou YF
    Zhonghua Bing Li Xue Za Zhi; 2009 Sep; 38(9):594-9. PubMed ID: 20079187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progesterone inhibition of Wnt/beta-catenin signaling in normal endometrium and endometrial cancer.
    Wang Y; Hanifi-Moghaddam P; Hanekamp EE; Kloosterboer HJ; Franken P; Veldscholte J; van Doorn HC; Ewing PC; Kim JJ; Grootegoed JA; Burger CW; Fodde R; Blok LJ
    Clin Cancer Res; 2009 Sep; 15(18):5784-93. PubMed ID: 19737954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. beta-Catenin expression pattern, beta-catenin gene mutations, and microsatellite instability in endometrioid ovarian carcinomas and synchronous endometrial carcinomas.
    Moreno-Bueno G; Gamallo C; Pérez-Gallego L; de Mora JC; Suárez A; Palacios J
    Diagn Mol Pathol; 2001 Jun; 10(2):116-22. PubMed ID: 11385321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical expression of E-cadherin and beta-catenin in the normal and malignant human endometrium: an inverse correlation between E-cadherin and nuclear beta-catenin expression.
    Shih HC; Shiozawa T; Miyamoto T; Kashima H; Feng YZ; Kurai M; Konishi I
    Anticancer Res; 2004; 24(6):3843-50. PubMed ID: 15736420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-catenin and E-cadherin expression patterns in high-grade endometrial carcinoma are associated with histological subtype.
    Schlosshauer PW; Ellenson LH; Soslow RA
    Mod Pathol; 2002 Oct; 15(10):1032-7. PubMed ID: 12379748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MMP-2, TIMP-1, E-cadherin, and beta-catenin expression in endometrial serous carcinoma compared with low-grade endometrial endometrioid carcinoma and proliferative endometrium.
    Shaco-Levy R; Sharabi S; Piura B; Sion-Vardy N
    Acta Obstet Gynecol Scand; 2008; 87(8):868-74. PubMed ID: 18607832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and significance of beta-catenin, Glut-1 and PTEN in proliferative endometrium, endometrial intraepithelial neoplasia and endometrioid adenocarcinoma.
    Xiong Y; Xiong YY; Zhou YF
    Eur J Gynaecol Oncol; 2010; 31(2):160-4. PubMed ID: 20527231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wnt/Β-catenin and sex hormone signaling in endometrial homeostasis and cancer.
    Wang Y; van der Zee M; Fodde R; Blok LJ
    Oncotarget; 2010 Nov; 1(7):674-684. PubMed ID: 21317462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endometrium-derived mesenchymal stem cells suppress progression of endometrial cancer via the DKK1-Wnt/β-catenin signaling pathway.
    Xu Y; Hu J; Lv Q; Shi C; Qiu M; Xie L; Liu W; Yang B; Shan W; Cheng Y; Zhao B; Chen X
    Stem Cell Res Ther; 2023 Jun; 14(1):159. PubMed ID: 37287079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crosstalk of estrogen receptors and Wnt/β-catenin signaling in endometrial cancer.
    Kasoha M; Dernektsi C; Seibold A; Bohle RM; Takacs Z; Ioan-Iulian I; Solomayer EF; Juhasz-Böss I
    J Cancer Res Clin Oncol; 2020 Feb; 146(2):315-327. PubMed ID: 31865530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. E-cadherin and β-catenin immunoexpression in endometrioid endometrial carcinoma.
    Florescu MM; Pirici D; Simionescu CE; Stepan AE; Mărgăritescu C; Tudorache Ş; Ciurea RN
    Rom J Morphol Embryol; 2016; 57(4):1235-1240. PubMed ID: 28174789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A mouse model for endometrioid ovarian cancer arising from the distal oviduct.
    van der Horst PH; van der Zee M; Heijmans-Antonissen C; Jia Y; DeMayo FJ; Lydon JP; van Deurzen CH; Ewing PC; Burger CW; Blok LJ
    Int J Cancer; 2014 Sep; 135(5):1028-37. PubMed ID: 24474556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant expression of hypoxia-inducible factor 1α, TWIST and E-cadherin is associated with aggressive tumor phenotypes in endometrioid endometrial carcinoma.
    Feng Z; Gan H; Cai Z; Li N; Yang Z; Lu G; Chen J
    Jpn J Clin Oncol; 2013 Apr; 43(4):396-403. PubMed ID: 23372184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical and genetic profiles of endometrioid endometrial carcinoma arising from atrophic endometrium.
    Geels YP; van der Putten LJ; van Tilborg AA; Lurkin I; Zwarthoff EC; Pijnenborg JM; van den Berg-van Erp SH; Snijders MP; Bulten J; Visscher DW; Dowdy SC; Massuger LF
    Gynecol Oncol; 2015 May; 137(2):245-51. PubMed ID: 25773202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SOX17, β-catenin and CyclinD1 expression in the endometrioid adenocarcinoma and influence of 5-AZA on expression.
    Liao YM; Song Y; Li YK; Du JH; Zhou Y
    Cancer Gene Ther; 2020 Apr; 27(3-4):256-263. PubMed ID: 31543512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel expression profiles and invasiveness-related biology function of DKK1 in endometrial carcinoma.
    Yi N; Liao QP; Li T; Xiong Y
    Oncol Rep; 2009 Jun; 21(6):1421-7. PubMed ID: 19424619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stromal Clues in Endometrial Carcinoma: Loss of Expression of β-Catenin, Epithelial-Mesenchymal Transition Regulators, and Estrogen-Progesterone Receptor.
    Senol S; Sayar I; Ceyran AB; Ibiloglu I; Akalin I; Firat U; Kosemetin D; Engin Zerk P; Aydin A
    Int J Gynecol Pathol; 2016 May; 35(3):238-48. PubMed ID: 26367784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunolocalization of ERK1/2 and p-AKT in normal endometrium, endometrial hyperplasia, and early and advanced stage endometrioid endometrial adenocancer and their prognostic significance in malignant group.
    Gungorduk K; Ertas IE; Sahbaz A; Ozvural S; Sarica Y; Ozdemir A; Sayhan S; Gokcu M; Yilmaz B; Sanci M; Inan S; Harma M; Yildirim Y
    Eur J Obstet Gynecol Reprod Biol; 2014 Aug; 179():147-52. PubMed ID: 24965996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.